| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Atenolol Pharmacokinetics and Excretion in Breast Milk During the First 6 to 8 Months Postpartum
|
Eyal, Sara
|
|
2010
|
50 |
11 |
p. 1301-1309
|
article
|
| 2 |
Bioequivalence Studies of Omnitrope, the First Biosimilar/rhGH Follow-on Protein: Two Comparative Phase 1 Randomized Studies and Population Pharmacokinetic Analysis
|
Stanhope, Richard
|
|
2010
|
50 |
11 |
p. 1339-1348
|
article
|
| 3 |
Clinical Efficacy and Pharmacokinetics of Antimony in Cutaneous Leishmaniasis Patients Treated With Sodium Stibogluconate
|
Zaghloul, Iman Y.
|
|
2010
|
50 |
11 |
p. 1230-1237
|
article
|
| 4 |
Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS-8958, in Healthy Male Volunteers
|
Ishizuka, Hitoshi
|
|
2010
|
50 |
11 |
p. 1319-1329
|
article
|
| 5 |
Development of a Population Pharmacokinetics-Based Sampling Schedule to Target Daily Intravenous Busulfan for Outpatient Clinic Administration
|
Salinger, David H.
|
|
2010
|
50 |
11 |
p. 1292-1300
|
article
|
| 6 |
Does the Long Plasma Half-Life of 4β-Hydroxycholesterol Impact Its Utility as a Cytochrome P450 3A (CYP3A) Metric?
|
Zheng Yang,
|
|
2010
|
50 |
11 |
p. 1330-1338
|
article
|
| 7 |
Effect of Sodium Alginate on Acid Gastroesophageal Reflux Disease in Preterm Infants: A Pilot Study
|
Atasay, Begum
|
|
2010
|
50 |
11 |
p. 1267-1272
|
article
|
| 8 |
Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes
|
Hale, Geoff
|
|
2010
|
50 |
11 |
p. 1238-1248
|
article
|
| 9 |
Pharmacokinetics and Pharmacodynamics of Three Moxifloxacin Dosage Forms: Implications for Blinding in Active-Controlled Cardiac Repolarization Studies
|
Mason, Jay W.
|
|
2010
|
50 |
11 |
p. 1249-1259
|
article
|
| 10 |
Population Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid Following Administration of Mycophenolate Mofetil in De Novo Pediatric Renal-Transplant Patients
|
Wei Zhao,
|
|
2010
|
50 |
11 |
p. 1280-1291
|
article
|
| 11 |
Single-Dose Safety, Pharmacokinetics, and Food Effects Studies of Compound Naphthoquine Phosphate Tablets in Healthy Volunteers
|
Heng Yan Qu,
|
|
2010
|
50 |
11 |
p. 1310-1318
|
article
|
| 12 |
Single Therapeutic and Supratherapeutic Doses of Laropiprant, a Selective Prostaglandin D 2 Receptor 1 Antagonist, Do Not Prolong the QTcF Interval in Healthy Volunteers
|
Luo, Wen-Lin
|
|
2010
|
50 |
11 |
p. 1273-1279
|
article
|
| 13 |
Sotrastaurin and Tacrolimus Coadministration: Effects on Pharmacokinetics and Biomarker Responses
|
Kovarik, John M.
|
|
2010
|
50 |
11 |
p. 1260-1266
|
article
|
Journal description